Medicinal inorganic chemistry offers additional opportunities for the design of therapeutic
agents not accessible to organic compounds. 1− 3 The wide range of coordination numbers …

History shows that metal-based drugs and remedies have been known and used since very
ancient times. For example, silver was employed in the treatment of wounds and ulcers …

We implemented isosteric replacement of sulfur to selenium in a novel thiosemicarbazone
(PPTP4c4mT) to create a selenosemicarbazone (PPTP4c4mSe) that demonstrates …

A new series of mononuclear copper (I) complexes (1–9) with functionalized 3-(2′-pyridyl)-
1, 2, 4-triazole chelating ligands, as well as the halide and/or phosphine ancillary ligands …

Three binuclear Schiff base copper (II) complexes:[Cu 2 (HL1) 2 (CH 3 OH)(NO 3)]· NO 3
(1),[Cu 2 (HL2) 2 (CH 3 OH) 2]· 2NO 3 (2), and [Cu 2 (HL3) 2 (C 2 H 5 OH) 2]· 2NO 3 …

The current work reports synthesis of metal complexes and mixed ligand complexes of a
novel sulfonamide Schiff base ligand (HL) resulted from the condensation of sulfametrole …

Three novel Cu (II) complexes 1 [Cu (L 1) 2], 2 [Cu (L 2) 2] and 3 [Cu (L 3) 2], where L 1 H= 2-
((3, 4-dimethylisoxazol-5-ylimino) methyl)-6-tert-butylphenol, L 2 H= 2-((3, 4 …

Cancer stem cells (CSCs) are thought to be partly responsible for metastasis and cancer
relapse. Currently, there are no effective therapeutic options that can remove CSCs at …

The group 11 metal complexes of two short-bite PNP ligands, C6H5N {P (OC6H3 (OMe-
o)(C3H5-p)) 2} 2 (1) and C6H5N {P (OC6H4C3H5-o) 2} 2 (2), are described. Ligands 1 and …

In this work, one oxidomethoxidovanadium (V)[VVO (L)(OMe)](1) and two mixed-ligand
oxidovanadium (IV)[V IV O (L)(phen)](2), and [V IV O (L)(bipy)](3) complexes have been …